Literature DB >> 30305347

Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark.

Signe T Andersen1, Daniel R Witte2,3, Jesper Fleischer4, Henning Andersen5, Torsten Lauritzen6, Marit E Jørgensen7,8, Troels S Jensen5,9, Rodica Pop-Busui10, Morten Charles6.   

Abstract

OBJECTIVE: To examine the course of cardiovascular autonomic neuropathy (CAN) and related cardiometabolic risk factors in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: CAN and cardiometabolic risk factors were assessed in the Danish arm of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Denmark) at 6-year (n = 777) and 13-year (n = 443) follow-up examinations. Cardiovascular autonomic reflex tests (CARTs)-that is, lying to standing, deep breathing, and the Valsalva maneuver-and 2-min resting heart rate variability (HRV) indices were obtained as the main measures of CAN. Risk factors related to CAN status, as determined by CARTs, were studied by using multivariate logistic regressions. The effects of risk factors on continuous CARTs and HRV indices, and their changes over time, were estimated in linear mixed models.
RESULTS: A progressive yet heterogeneous course of CAN occurred between the 6- and 13-year follow-ups. Higher HbA1c, weight, BMI, and triglycerides were associated with prevalent CAN. No significant effect of risk factors on CARTs was found when they were analyzed as continuous variables. CART indices decreased over time, and a trend of decreasing HRV indices was seen. Higher HbA1c and BMI were associated with lower HRV index values, but these differences diminished over time.
CONCLUSIONS: These data confirm that hyperglycemia, obesity, and hypertriglyceridemia are negatively related to indices of CAN, although these effects diminish over time. The observed heterogeneous course of CAN may challenge the present clinical approach of categorically classifying CARTs to diagnose CAN and the notion of CAN being irreversible.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2018        PMID: 30305347     DOI: 10.2337/dc18-1411

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  23 in total

1.  CrossTalk proposal: Heart rate variability is a valid measure of cardiac autonomic responsiveness.

Authors:  Marek Malik; Katerina Hnatkova; Heikki V Huikuri; Federico Lombardi; Georg Schmidt; Markus Zabel
Journal:  J Physiol       Date:  2019-04-21       Impact factor: 5.182

2.  The cross-sectional association of cognition with diabetic peripheral and autonomic neuropathy-The GRADE study.

Authors:  Joshua I Barzilay; Alokananda Ghosh; Rodica Pop Busui; Andrew Ahmann; Ashok Balasubramanyam; Mary Ann Banerji; Robert M Cohen; Jennifer Green; Faramarz Ismail-Beigi; Catherine L Martin; Elizabeth Seaquist; José A Luchsinger
Journal:  J Diabetes Complications       Date:  2021-09-15       Impact factor: 2.852

3.  The Predictive Value of Serum Calcium on Heart Rate Variability and Cardiac Function in Type 2 Diabetes Patients.

Authors:  Junyi Wang; Zihui Xu; Kang Lv; Yingchun Ye; Deng Luo; Li Wan; Fen Zhou; Ailin Yu; Shuo Wang; Jingcheng Liu; Ling Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

4.  Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism.

Authors:  Christian S Hansen; Tommi Suvitaival; Simone Theilade; Ismo Mattila; Maria Lajer; Kajetan Trošt; Linda Ahonen; Tine W Hansen; Cristina Legido-Quigley; Peter Rossing; Tarunveer S Ahluwalia
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

5.  Distal Symmetric and Cardiovascular Autonomic Neuropathies in Brazilian Individuals with Type 2 Diabetes Followed in a Primary Health Care Unit: A Cross-Sectional Study.

Authors:  Mozania Reis de Matos; Daniele Pereira Santos-Bezerra; Cristiane das Graças Dias Cavalcante; Jacira Xavier de Carvalho; Juliana Leite; Jose Antonio Januario Neves; Sharon Nina Admoni; Marisa Passarelli; Maria Candida Parisi; Maria Lucia Correa-Giannella
Journal:  Int J Environ Res Public Health       Date:  2020-05-06       Impact factor: 3.390

Review 6.  Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet.

Authors:  Vincenza Spallone
Journal:  Diabetes Metab J       Date:  2019-02       Impact factor: 5.376

7.  Subclinical inflammation and endothelial dysfunction are linked to cardiac autonomic neuropathy in type 2 diabetes.

Authors:  Pooja Bhati; Rizwan Alam; Jamal Ali Moiz; M Ejaz Hussain
Journal:  J Diabetes Metab Disord       Date:  2019-08-31

8.  Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial.

Authors:  Yaling Tang; Hetal Shah; Carlos Roberto Bueno Junior; Xiuqin Sun; Joanna Mitri; Maria Sambataro; Luisa Sambado; Hertzel C Gerstein; Vivian Fonseca; Alessandro Doria; Rodica Pop-Busui
Journal:  Diabetes Care       Date:  2020-11-03       Impact factor: 19.112

9.  Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy.

Authors:  Mette W Klinge; Nanna Sutter; Esben B Mark; Anne-Mette Haase; Per Borghammer; Vincent Schlageter; Sten Lund; Jesper Fleischer; Karoline Knudsen; Asbjørn M Drewes; Klaus Krogh
Journal:  J Neurogastroenterol Motil       Date:  2021-07-30       Impact factor: 4.924

10.  The role of abnormalities of lipoproteins and HDL functionality in small fibre dysfunction in people with severe obesity.

Authors:  Shazli Azmi; Maryam Ferdousi; Yifen Liu; Safwaan Adam; Tarza Siahmansur; Georgios Ponirakis; Andrew Marshall; Ioannis N Petropoulos; Jan Hoong Ho; Akheel A Syed; John M Gibson; Basil J Ammori; Paul N Durrington; Rayaz A Malik; Handrean Soran
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.